Searched for
UDAY BALDOTA
Govt slaps fine on Sun Pharma officials over related party transactionsSun Pharmaceutical Industries Ltd has been penalized by the Ministry of Corporate Affairs for non-disclosure and failure to obtain necessar...- Govt slaps fine on Sun Pharma officials over related party transactionsSun Pharmaceutical Industries Ltd has been penalized by the Ministry of Corporate Affairs for non-disclosure and failure to obtain necessar...
- Taro shareholders approve merger with Sun PharmaThe combined entity will enable the company to better serve the needs of patients, healthcare professionals and customers around the world,...
- Sun Pharma to buy remaining 21.5% in Taro for Rs 2,892 crSun Pharma, India's largest drugmaker, is set to acquire the remaining 21.52% stake in Israel-based Taro Pharmaceutical Industries for ₹2,8...
- Sun Pharma settles fund diversion case with SebiThe move could be a booster for Sun Pharma shares as corporate governance issues have weighed investor sentiment for the past two years.
- Sun Pharma, officials including Dilip Shanghvi settle case of alleged mkt norms violation with SebiThe firm's whole-time directors - Sudhir V Valia and Sailesh T Desai - paid Rs 37.41 lakh each, and Kalyanasundaram Subramanian had to remi...
- Aditya Medisales case: Sebi accepts settlement pleas of Sun Pharma, promotersSebi had initiated a probe against Sun Pharma, its managing director Dilip Shanghvi and its directors on the basis of two whistleblower com...
- Sun Pharma investors jittery about promoter's non-core movesThe company, last Thursday, announced the acquisition of an oncology product for launch in global mar kets. This is the company's third acq...
- Taro appoints Sun Pharma CFO Uday Baldota its CEOBaldota, who has also been nominated to Taro's board of directors, is expected to begin his role as CEO on or about April 1, 2017, and will...
- Sun Pharma in process to integrate Ranbaxy, overhauls combined global operationsThe sprawling site has been blocked by the US Food and Drug Administration since 2008 following revelations of manipulation of data.
- Sun Pharma shares fall over 2%; slip for second day in a row on US FDA concernsThe stock has fallen on reports that Halol plant in Gujarat has been subjected to surprise inspection by the American drug regulator USFDA.
- Sun Pharmaceutical's woes deepen as US arm Taro recalls Warfarin from marketsThis is the third such recall for Sun which agreed to buy troubled fellow drug maker Ranbaxy in March this year to create the world's fifth...
- Sun-Ranbaxy deal: How India’s biggest pharma merger is also the quickest to get done, stitched up in just 2 monthsSun and their Japanese counterparts met for the first time as recently as the third week of March. A final agreement was in place by the en...
- Sun Pharma says won't revise taro offer priceMumbai-based Sun Pharma will not revise its offer price to minority shareholders of Isreali drug maker Taro pharma, a company official said.
- Sun rejects Guggenheim’s $215 mn offer for Taro stakeGuggenheim Partners offered to buy Sun Pharmaceutical Industries’ stake in Taro Pharmaceuticals Industries on behalf of clients for about $...
- Lilly sues Sun Pharma to block Strattera copyEli Lilly sued India's Sun Pharmaceutical Industries to prevent it from selling a generic version of the hyperactivity-disorder drug Stratt...
- Sun Pharma eyes acquisition in USSun Pharmaceuticals has prepared a war chest of $500 million for acquisitions in the US, as it bets big on the world's largest drugs market.
Load More
